Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains

J Virol. 1995 Jun;69(6):3824-30. doi: 10.1128/JVI.69.6.3824-3830.1995.

Abstract

The matrix (MA) protein of human immunodeficiency virus type 1 (HIV-1) forms the outer protein shell directly underneath the lipid envelope of the virion. The MA protein has a key role in different aspects of virus assembly, including the incorporation of the HIV-1 Env protein complex, which contains a transmembrane glycoprotein with an unusually long cytoplasmic tail. In this study, we compared the abilities of HIV-1 MA mutants to incorporate Env protein complexes with long and short cytoplasmic tails. While the mutant particles failed to incorporate the authentic HIV-1 Env protein complex, they retained the ability to efficiently and functionally incorporate the amphotropic murine leukemia virus Env protein complex, which has a short cytoplasmic tail. Moreover, incorporation of the autologous Env protein complex could be restored by a second-site mutation that resulted in the truncation of the cytoplasmic tail of the HIV-1 transmembrane glycoprotein. Remarkably, the second-site mutation also restored the ability of MA mutants to replicate in MT-4 cells. These results imply that the long cytoplasmic tail of the transmembrane glycoprotein is responsible for the exclusion of the HIV-1 Env protein complex from MA mutant particles.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cytoplasm / metabolism
  • Gene Products, env / genetics
  • Gene Products, env / metabolism*
  • Gene Products, gag / genetics
  • Gene Products, gag / metabolism*
  • HIV Antigens / genetics
  • HIV Antigens / metabolism*
  • HIV-1 / genetics
  • HIV-1 / metabolism*
  • HIV-1 / pathogenicity
  • HeLa Cells
  • Humans
  • Leukemia Virus, Murine / genetics
  • Mutation
  • Viral Proteins*
  • Virus Replication / genetics
  • gag Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, env
  • Gene Products, gag
  • HIV Antigens
  • Viral Proteins
  • gag Gene Products, Human Immunodeficiency Virus
  • p17 protein, Human Immunodeficiency Virus Type 1